Company Performance Metrics
- Yannick Erbs: CEO
AgeX Therapeutics is a biotechnology company focused on the development of regenerative therapies for age-related conditions. It utilizes proprietary technologies such as PureStem®, UniverCyte™, and induced Tissue Regeneration (iTR™) to create cell-based treatments. The company’s research explores therapeutic applications involving brown adipocytes
and vascular progenitor cells for metabolic and ischemic diseases. Its approach involves the use of pluripotent stem cells to generate differentiated cell types with potential clinical uses. AgeX also investigates methods to reduce immune rejection through gene-editing and cell engineering. It conducts preclinical and strategic development in collaboration with research institutions and partners. AgeX operates within the biotech sector with an emphasis on therapeutic innovation and regulatory compliance.